Company Search:
Advanced Search
Sponsored Links
Kangmei Pharmaceutical Co Ltd Company Snapshot
Kangmei Pharmaceutical Co Ltd operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kangmei Pharmaceutical Co Ltd with three other companies in this sector in China: Apeloa Pharmaceutical Co Ltd (2017 sales of 5.55 billion Chinese Renmimbi [US$820.44 million] of which 100% was Health Care & Pharmaceutical), Zhejiang Nhu Co Ltd (6.23 billion Chinese Renmimbi [US$920.14 million] of which 95% was Pharmaceutical Chemicals), and China Resources Double-Crane Pharmaceutical Company Limited (6.42 billion Chinese Renmimbi [US$949.02 million] of which 68% was Non- transfusion).

Sales Analysis. Kangmei Pharmaceutical Co Ltd reported sales of 26.48 billion Chinese Renmimbi (US$3.91 billion) for the year ending December of 2017. This represents an increase of 22.5% versus 2016, when the company's sales were 21.61 billion Chinese Renmimbi. Sales at Kangmei Pharmaceutical Co Ltd have increased during each of the previous five years (and since 2012, sales have increased a total of 137%). Sales of Other Operation saw an increase that was more than double the company's growth rate: sales were up 67.7% in 2017, from 66.58 million Chinese Renmimbi to 111.67 million Chinese Renmimbi. Not all segments of Kangmei Pharmaceutical Co Ltd experienced an increase in sales in 2017: sales of Other (Main) fell 17.1% to 781.85 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kangmei Pharmaceutical Co Ltd
  Stock Performance Chart for Kangmei Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 9.20
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 25.2%  
4 Weeks -25.0%   52 Weeks -56.3%  
Kangmei Pharmaceutical Co Ltd Key Data:
  Ticker: 600518 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 26,476,955,801
(Year Ending Jan 2018).
Employees: 11,219
  Currency: Chinese Renmimbi Market Cap: 45,382,723,010
  Fiscal Yr Ends: December Shares Outstanding: 4,932,904,675
  Share Type: A Gu Closely Held Shares: 2,654,902,811
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.